Communicating infection control advice to the Norwegian public using a web-based Message Lab study
| ISRCTN | ISRCTN11075577 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN11075577 |
| Sponsor | Norwegian Institute of Public Health |
| Funder | Norwegian Institute of Public Health |
- Submission date
- 20/04/2026
- Registration date
- 27/04/2026
- Last edited
- 07/05/2026
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Infections and Infestations
Plain English summary of protocol
Background and study aims
Institutes of Public Health often have responsibility for developing and communicating health advice to the public. It is not always evident how well the advice is understood among members of the public. This study will explore the effect of providing additional explanations of key terms and adding specific advice related to staying at home on intended behaviour.
Who can participate?
Healthy volunteers aged between 20 to 66 years old (working age), who speak Norwegian as native language, and reside in Norway.
What does the study involve?
The study will conduct a web-based, parallel-group, individually randomized, pragmatic superiority trial to compare the effects of different ways of communicating health advice related to newly onset symptoms of a respiratory tract infection.
What are the possible benefits and risks of participating?
The findings from this study will inform the format and wording of health advice communicated by the National Institute of Public Health.
Risks not provided at time of registration
Where is the study run from?
Norwegian Institute of Public Health, Norway.
When is the study starting and how long is it expected to run for?
April 2026 to June 2026
Who is funding the study?
Norwegian Institute of Public Health, Norway.
Who is the main contact?
Dr Heather Munthe-Kaas, heather.munthe-kaas@fhi.no
Contact information
Principal investigator, Public, Scientific
Lovisenberggata 8
Oslo
0456
Norway
| 0000-0002-6051-9010 | |
| Phone | +47 40293266 |
| heather.munthe-kaas@fhi.no |
Study information
| Primary study design | Interventional |
|---|---|
| Allocation | Randomized controlled trial |
| Masking | Blinded (masking used) |
| Control | Active |
| Assignment | Parallel |
| Purpose | Basic science, Health services research |
| Scientific title | Communicating infection control advice to the Norwegian public: web-based randomized superiority message lab trial |
| Study objectives | The objectives of this randomized trial are to estimate the effects of four different modes of communicating advice related to behaviour with newly onset symptoms of respiratory infection. The primary outcome is intended behaviour based on health advice |
| Ethics approval(s) |
Approved 23/04/2026, REK south-east B (Regional Committees for Medical and Health Research Ethics, Postboks 1130 Blindern, Oslo, 0318, Norway; +47 22845501; rek-sorost@medisin.uio.no), ref: 986882 |
| Health condition(s) or problem(s) studied | Intended behaviour based on infection control advice. |
| Intervention | Intervention description (TIDieR summary) and study-arm procedures This is a web-based, individually randomised, parallel-group Message Lab trial delivered through the University of Oslo survey platform (Nettskjema; Norwegian; an English back-translation is provided in the protocol for reference). The study will use an automated, computer-based randomization process implemented in Nettskjema to allocate participants 1:1:1:1 to control or intervention. Randomization will be triggered when participants confirm study participation by clicking a button. Allocation will be concealed and handled independently of the research team, who will not have access to the randomization sequence or ability to influence treatment assignment. After opening the invitation email and providing electronic informed consent, participants complete baseline questions and an attention check. Participants are then automatically allocated to view one version of infection-control advice text about what to do when experiencing newly onset respiratory symptoms. Immediately after reading the allocated advice, participants complete outcome questions (hypothetical scenarios and additional items on understanding, trustworthiness and perceived sufficiency of information) and then submit their responses. No additional study contact or reminders are planned. Duration and follow-up (all arms): The intervention consists of a single exposure to the allocated advice text during one online session (expected completion time approximately 5–10 minutes for the full survey). Outcomes are assessed once, immediately after exposure, within the same session (no longitudinal follow-up). Study arms (what is delivered): Arm 1 – Explanations of key terms (version with explicit descriptions): Participants view the advice text that includes explicit explanations/definitions of key terms describing vulnerable groups (e.g., defining “infants” and “people at higher risk of becoming seriously ill”). The core behavioural recommendation is to avoid unnecessary close contact with people at higher risk and to practise respiratory/hand hygiene. The advice is presented as plain text on-screen in Nettskjema. No tailoring or personalisation is used beyond presenting the same text to all participants assigned to this arm. Arm 2 – Explanations + ‘usually okay to attend’ sentence: Participants view the advice text that includes (i) explicit explanations/definitions of key terms as in Arm 1, and (ii) an additional sentence stating that it is usually okay to go to work or participate in other activities if the person feels well enough, while still taking precautions to avoid infecting others. The advice is presented as plain text on-screen in Nettskjema, identical for all participants in this arm (no tailoring). Arm 3 – Current Norwegian Institute of Public Health (NIPH) web advice + ‘usually okay to attend’ sentence: Participants view the current NIPH website wording for advice about behaviour with respiratory symptoms, with an additional sentence stating that it is usually okay to go to work or participate in activities if the person feels up to it. The advice is presented as plain text on-screen in Nettskjema, identical for all participants allocated to this arm (no tailoring). Arm 4 – Control (current NIPH web advice): Participants view the current NIPH website wording for advice about staying at home/behaviour when experiencing respiratory symptoms, without additional explanations of key terms and without the added sentence about it usually being okay to go to work/participate if feeling well enough. The advice is presented as plain text on-screen in Nettskjema, identical for all participants allocated to this arm. Who provides and how: The interventions are informational messages developed by the research team based on NIPH infection-control advice and are delivered automatically by the survey platform; there is no clinician or facilitator. The messages are read by participants on their own devices. The research team will conduct user testing (three rounds as described below) and may refine wording/formatting prior to recruitment; any changes will preserve the intended contrasts between arms (presence/absence of explanations of key terms and presence/absence of the additional ‘usually okay to go to work/participate’ sentence). |
| Intervention type | Other |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) |
|
| Completion date | 29/06/2026 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Mixed |
| Lower age limit | 20 Years |
| Upper age limit | 66 Years |
| Sex | All |
| Target sample size at registration | 1600 |
| Key inclusion criteria | 1. Aged between 20 to 66 years old (working age) 2. Have Norwegian as native language 3. Reside in Norway |
| Key exclusion criteria | Not meeting the key inclusion criteria. |
| Date of first enrolment | 27/04/2026 |
| Date of final enrolment | 12/05/2026 |
Locations
Countries of recruitment
- Norway
Study participating centres
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol file | version 1.3 | 08/04/2026 | 20/04/2026 | No | No |
Additional files
- 49389_Protocol_v1.3_08April2026.pdf
- Protocol file
Editorial Notes
07/05/2026: The date of final enrolment was changed from 04/05/2026 to 12/05/2026.
27/04/2026: Study’s existence confirmed by the Regional Committee for Medical and Health Research Ethics (REK) South-East B, Norway.